PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeuticsSajid Khan, Daohong Zhou, Yonghan He et al.|Oncogene|2020Cited by 241
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic DevelopmentHu Li, Yonghan He, Daohong Zhou et al.|Frontiers in Cell and Developmental Biology|2022Cited by 147
Ursolic Acid Inhibits Adipogenesis in 3T3-L1 Adipocytes through LKB1/AMPK PathwayYonghan He, Changhao Sun|PLoS ONE|2013Cited by 142
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomasYonghan He, Daohong Zhou|Journal of Hematology & Oncology|2020Cited by 129
Bioactivities of EF24, a Novel Curcumin Analog: A ReviewYonghan He, Qing‐Peng Kong, Wen Li et al.|Frontiers in Oncology|2018Cited by 89